Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

7.37
Delayed Data
As of 3:59pm ET
 +0.30 / +4.24%
Today’s Change
6.75
Today|||52-Week Range
36.38
-55.44%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close7.07
Today’s open7.11
Day’s range6.95 - 7.41
Volume231,307
Average volume (3 months)326,885
Market cap$175.5M
Dividend yield--
Data as of 3:59pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+2.70%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...-0.03-0.59%
BPTHBio Path Holdings In...+0.02+1.02%
AKTXAkari Therapeutics P...-1.05-7.21%
ENZYEnzymotec Ltd+0.34+4.24%
Data as of 4:00pm ET, 06/30/2016

Financials

Next reporting dateAugust 25, 2016
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Don Soland
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers

Search for Jobs